Home / Companies / Ultragenyx Pharmaceutical Inc. / 18 Jun 2024
Ultragenyx Pharmaceutical Inc.: meeting of 18 Jun 2024
Votes reported on Form N-PX, item by item
457 Form N-PX filers reported votes at the Ultragenyx Pharmaceutical Inc. meeting of 18 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 85.4% of reported votes for; 32 filers withheld from or voted against at least one nominee.
916 vote records from 177 filers. 28 of the 176 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
642 vote records from 455 filers. 212 of the 440 filers that marked the item either way voted against management. 15 filers reported this item without a management mark.
2 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
306 vote records from 177 filers. 2 of the 176 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
307 vote records from 178 filers. 98 of the 177 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | For | Against * | For |
| State Street and SPDR | For | For | For |
| American Century | For | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | For | For | For |
| Equitable | Abstain or withhold * | Against * | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Abstain or withhold * | Against * | For |
| PGIM and Prudential | Abstain or withhold * | For | For |
| Jackson National funds | For | For | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | For | For |
| T. Rowe Price | Abstain or withhold * | For | For |
| Lincoln Financial | For | Against | For |
| Voya | For | For | For |
| First Trust | For | Against * | For |
| Russell Investments | For | For | For |
| Nationwide | For | Against * | For |
| Victory Capital | For | Against * | For |
| Brighthouse Funds | Abstain or withhold * | For | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | Abstain or withhold * | Against * | For |
| Principal | Abstain or withhold * | For | For |
| Pacific Life funds | For | Against * | For |
| Global X | For | For | For |
| MFS | For | Against * | For |
| Transamerica | Abstain or withhold * | For | For |
| Federated Hermes | For | For | For |
| AllianceBernstein | Abstain or withhold * | Against * | For |
| Hartford Funds | For | For | For |
| DWS | For | Against * | For |
| Allspring | For | Against * | For |
| MassMutual | For | For | For |
| Virtus | For | Against * | For |
| Macquarie and Delaware Funds | For | Against * | For |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | For | No report |
| Natixis and Loomis Sayles | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Ultragenyx Pharmaceutical Inc. meeting?
457 Form N-PX filers reported votes at the meeting of 18 Jun 2024. On say-on-pay, 212 of 440 voted against management (48.2%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Ultragenyx Pharmaceutical Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Ultragenyx Pharmaceutical Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Ultragenyx Pharmaceutical Inc. with a meeting date within three days of 18 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.